| NCT06209736 | Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN | RECRUITING | PHASE2 | 2024-03-01 | 2026-04 | 2026-01 |
| NCT06298955 | Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria | RECRUITING | PHASE2 | 2024-02-19 | 2027-04 | 2026-12 |
| NCT05855083 | Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA | RECRUITING | PHASE2 | 2023-05-01 | 2025-12 | 2025-12 |
| NCT05972967 | Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab | COMPLETED | PHASE2 | 2023-03-27 | 2024-10-10 | 2024-10-10 |
| NCT05889299 | Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria | UNKNOWN | PHASE1 | 2022-12-09 | 2024-06-30 | 2023-10-30 |
| NCT03608033 | Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy | TERMINATED | PHASE3 | 2018-02-16 | 2023-10-18 | 2023-10-16 |
| NCT03205995 | Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome | RECRUITING | PHASE3 | 2017-02-23 | 2020-02 | 2020-02 |
| NCT02682407 | Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 | UNKNOWN | PHASE2 | 2016-02 | 2020-12 | 2020-12 |
| NCT02222545 | Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies | COMPLETED | PHASE2 | 2014-11-02 | 2020-08-11 | 2020-01-30 |
| NCT02132312 | A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement | COMPLETED | PHASE3 | 2014-07 | 2016-09-12 | 2016-09-12 |
| NCT02093689 | Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery | TERMINATED | PHASE3 | 2014-02 | 2014-08 | 2014-08 |
| NCT02074410 | Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease | TERMINATED | PHASE2 | 2014-01 | 2014-10-15 | 2014-10-15 |
| NCT01952132 | Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects | COMPLETED | PHASE2 | 2013-09 | 2014-04 | 2014-04 |
| NCT01579565 | Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification | COMPLETED | PHASE3 | 2012-04 | 2013-01 | 2012-11 |
| NCT01454063 | Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification | COMPLETED | PHASE3 | 2011-09 | 2012-03 | 2012-03 |
| NCT01406561 | Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy | COMPLETED | PHASE3 | 2011-08 | 2012-12 | 2012-11 |
| NCT01193127 | Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR) | COMPLETED | PHASE2 | 2010-07 | 2011-02 | 2011-01 |
| NCT00857090 | Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones | COMPLETED | PHASE1, PHASE2 | 2009-03 | 2010-12 | 2010-12 |
| NCT00721695 | Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification. | COMPLETED | PHASE1, PHASE2 | 2008-05 | 2009-02 | 2009-02 |
| NCT00624845 | Double-Blind, Multicenter, Study Comparing the Efficacy and Safety of OMS103HP With Vehicle Irrigation Solution in Subjects Undergoing Meniscectomy | COMPLETED | PHASE2, PHASE3 | 2007-12 | 2009-05 | 2009-05 |
| NCT00599664 | Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones | COMPLETED | PHASE1 | 2007-12 | 2008-09 | |
| NCT00226772 | Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction | COMPLETED | PHASE3 | 2005-06 | 2011-03 | 2010-09 |
| NCT00226759 | Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction | COMPLETED | PHASE3 | 2004-11 | 2011-03 | 2010-09 |
| NCT00245271 | Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction | COMPLETED | PHASE3 | 2004-10 | 2011-03 | 2010-03 |